In the dynamic landscape of pharmaceutical research and development, certain chemical compounds emerge as indispensable cornerstones for therapeutic breakthroughs. Among these, 7-methoxy-8-methyl-2-(4-propan-2-yl-1,3-thiazol-2-yl)-1H-quinolin-4-one stands out. Identified by its CAS number 923289-21-8, this complex molecule is far more than just a chemical entity; it is a critical intermediate that bridges the gap between basic chemical synthesis and advanced medicinal products. NINGBO INNO PHARMCHEM CO.,LTD. is committed to providing high-quality intermediates like this one, supporting the global effort to combat prevalent diseases.

The primary significance of this quinoline derivative lies in its indispensable role in the synthesis of Simeprevir. Simeprevir is a highly effective antiviral medication primarily used to treat Hepatitis C, a chronic liver infection that affects millions worldwide. The structural intricacies of 7-methoxy-8-methyl-2-(4-propan-2-yl-1,3-thiazol-2-yl)-1H-quinolin-4-one provide a stable and reactive scaffold that medicinal chemists leverage to build the final, complex structure of Simeprevir. This reliance on a high-purity intermediate underscores the importance of quality control in pharmaceutical manufacturing. For those looking to secure a reliable supply of this compound, understanding the CAS 923289-21-8 chemical properties and ensuring a consistent product from a reputable pharmaceutical intermediate supplier in China is paramount.

The chemical profile of 7-methoxy-8-methyl-2-(4-propan-2-yl-1,3-thiazol-2-yl)-1H-quinolin-4-one is characterized by its appearance as a white solid, a molecular formula of C17H18N2O2S, and a molecular weight of 314.402. Its assay is specified at ≥99.0%, with minimal water content (≤0.5%) and sulphated ash (≤0.1%). These stringent specifications are crucial for ensuring the efficacy and safety of the final pharmaceutical product. The journey from raw chemical materials to a finished drug product is a complex one, and the quality of each intermediate, such as this quinoline derivative, directly impacts the outcome. Pharmaceutical companies often seek out specialized API intermediate manufacturing expertise to ensure they are meeting regulatory requirements and producing the safest, most effective treatments possible.

The global demand for effective Hepatitis C treatments continues to grow, driving the need for reliable sourcing of essential intermediates. China has emerged as a significant player in the global chemical manufacturing sector, offering cost-effective production capabilities alongside advanced technological processes. When seeking a pharmaceutical intermediate supplier in China, companies prioritize those who can guarantee consistent quality, adherence to international standards, and a robust supply chain. The availability of high-quality 7-methoxy-8-methyl-2-(4-propan-2-yl-1,3-thiazol-2-yl)-1H-quinolin-4-one is therefore critical for pharmaceutical companies aiming to scale up production of antiviral medications. NINGBO INNO PHARMCHEM CO.,LTD. is dedicated to fulfilling this need, offering expertise in chemical synthesis and a commitment to product excellence.

In conclusion, 7-methoxy-8-methyl-2-(4-propan-2-yl-1,3-thiazol-2-yl)-1H-quinolin-4-one is more than just a chemical compound; it is a vital link in the chain of pharmaceutical innovation, particularly in the fight against Hepatitis C. Its precise chemical properties, combined with a commitment to quality from manufacturers, ensure that life-saving medications can be produced efficiently and effectively. For businesses involved in the pharmaceutical sector, partnering with experienced suppliers of such critical intermediates is a strategic imperative.